Drug Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

Drug Name AZD8186
Trade Name
Drug Descriptions

AZD8186 selectively inhibits the activity of PI3Kbeta (PIK3CB) and delta (PIK3CD) in the PI3K/Akt/mTOR signaling pathway, which may result in decreased tumor cell proliferation (PMID: 25514658).

DrugClasses PIK3CB inhibitor 8 PIK3CD inhibitor 25


  • Case insensitive filtering will display rows where any text in any cell matches the filter term
  • Simple literal full or partial string matches
  • Separate multiple filter terms with a spaces, order doesn't matter (a b c and c b a are equivalent )
  • Filtering will only apply to rows that are already loaded on the page, filtering has no impact on query parameters
  • Use quotes to match a longer phrase which contains spaces "mtor c1483f"


  • Generally, the default sort order for tables is set to be first column ascending, however, specific tables may set a different default sort order.
  • Click on any column header arrows to sort by that column
  • Hold down the Shift key and click multiple columns to sort by more than one column, be sure to set ascending or descending order for a given column, before moving on to the next column.

Therapy Name Drugs Efficacy Evidence Clinical Trials
Abiraterone + AZD8186 AZD8186 Abiraterone 0 1
Alpelisib + AZD8186 AZD8186 Alpelisib 0 0
Alpelisib + AZD8186 + Enzalutamide AZD8186 Alpelisib Enzalutamide 0 0
AZD8186 AZD8186 3 1
AZD8186 + Docetaxel AZD8186 Docetaxel 0 1
AZD8186 + Enzalutamide AZD8186 Enzalutamide 0 0
AZD8186 + SCH772984 AZD8186 SCH772984 0 0
AZD8186 + Ulixertinib AZD8186 Ulixertinib 0 0
AZD8186 + Vistusertib AZD8186 Vistusertib 1 1

Additional content available in CKB BOOST